Crossmark

A strategy for synergistic enhancement of immune circulation in head and neck squamous cell carcinoma by novel nucleic acid drug therapy and immunotherapy

Crossref DOI link: https://doi.org/10.1186/s12967-025-06344-2

Published Online: 2025-03-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hong, Yangjian

Liu, Yanyang

Shen, Huize

Li, Bowen

Li, Qinglin https://orcid.org/0000-0001-8469-0923
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82173346, 82474317)

Medical Science and Technology Project of Zhejiang Province (2020PY002)

Zhejiang Traditional Chinese Medicine Administration (2020ZQ005)
License Information

Text and Data Mining valid from 2025-03-20

Version of Record valid from 2025-03-20
More Information

Article History

Received: 6 January 2025

Accepted: 1 March 2025

First Online: 20 March 2025

Declarations

:

: Declarations.

: Declarations.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below